BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,090 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,272,813 | -92.8% | 86,720 | -91.4% | 0.01% | -92.9% |
| Q2 2023 | $45,739,825 | -13.6% | 1,003,947 | -23.1% | 0.10% | -16.8% |
| Q1 2023 | $52,944,874 | +102.6% | 1,305,347 | +154.6% | 0.12% | +88.9% |
| Q4 2022 | $26,134,715 | -5.4% | 512,747 | -0.1% | 0.06% | -8.7% |
| Q3 2022 | $27,633,000 | +1.4% | 513,047 | +20.9% | 0.07% | +11.3% |
| Q2 2022 | $27,262,000 | -38.6% | 424,447 | -25.9% | 0.06% | -26.2% |
| Q1 2022 | $44,419,000 | -52.2% | 572,847 | -47.1% | 0.08% | -49.7% |
| Q4 2021 | $93,012,000 | +1.8% | 1,083,547 | -4.6% | 0.17% | -7.2% |
| Q3 2021 | $91,372,000 | +107.0% | 1,136,047 | +107.1% | 0.18% | +109.3% |
| Q2 2021 | $44,150,000 | -43.3% | 548,447 | -40.6% | 0.09% | -45.9% |
| Q1 2021 | $77,838,000 | +70.5% | 922,902 | +62.2% | 0.16% | +59.0% |
| Q4 2020 | $45,657,000 | +0.6% | 569,002 | +0.8% | 0.10% | -12.3% |
| Q3 2020 | $45,377,000 | -48.8% | 564,252 | -45.2% | 0.11% | -49.8% |
| Q2 2020 | $88,627,000 | -9.2% | 1,029,352 | -14.4% | 0.23% | -22.0% |
| Q1 2020 | $97,593,000 | +30.4% | 1,202,028 | +34.3% | 0.29% | +58.2% |
| Q4 2019 | $74,866,000 | +7.6% | 895,316 | +12.6% | 0.18% | +7.6% |
| Q3 2019 | $69,573,000 | +46.5% | 795,397 | +37.2% | 0.17% | +44.9% |
| Q2 2019 | $47,485,000 | -2.4% | 579,797 | -3.1% | 0.12% | -3.3% |
| Q1 2019 | $48,629,000 | +64.1% | 598,063 | +32.9% | 0.12% | +48.8% |
| Q4 2018 | $29,628,000 | -44.0% | 450,137 | -34.4% | 0.08% | -30.5% |
| Q3 2018 | $52,896,000 | -18.1% | 686,165 | -21.6% | 0.12% | -20.3% |
| Q2 2018 | $64,603,000 | +73.2% | 874,899 | +52.6% | 0.15% | +70.1% |
| Q1 2018 | $37,294,000 | -43.0% | 573,399 | -43.4% | 0.09% | -41.2% |
| Q4 2017 | $65,451,000 | +46.0% | 1,012,541 | +41.7% | 0.15% | +35.8% |
| Q3 2017 | $44,837,000 | +46.8% | 714,526 | +41.7% | 0.11% | +45.3% |
| Q2 2017 | $30,538,000 | +39.4% | 504,421 | +19.4% | 0.08% | +36.4% |
| Q1 2017 | $21,913,000 | -27.1% | 422,546 | -37.6% | 0.06% | -32.9% |
| Q4 2016 | $30,042,000 | -3.8% | 677,546 | +3.3% | 0.08% | -4.7% |
| Q3 2016 | $31,213,000 | -16.4% | 655,738 | -20.6% | 0.09% | -15.7% |
| Q2 2016 | $37,349,000 | +27.2% | 825,938 | +15.6% | 0.10% | +27.5% |
| Q1 2016 | $29,351,000 | +320.2% | 714,487 | +290.2% | 0.08% | +344.4% |
| Q4 2015 | $6,985,000 | -89.2% | 183,098 | -80.3% | 0.02% | -88.9% |
| Q2 2015 | $64,951,000 | +13.1% | 928,798 | +10.8% | 0.16% | +15.7% |
| Q1 2015 | $57,410,000 | +148.2% | 838,098 | +165.6% | 0.14% | +145.6% |
| Q4 2014 | $23,130,000 | -58.1% | 315,598 | -59.0% | 0.06% | -58.4% |
| Q3 2014 | $55,263,000 | +42.3% | 769,998 | +43.3% | 0.14% | +37.0% |
| Q2 2014 | $38,839,000 | -32.6% | 537,198 | -31.4% | 0.10% | -36.3% |
| Q1 2014 | $57,650,000 | +1.4% | 783,498 | -4.1% | 0.16% | +4.0% |
| Q4 2013 | $56,850,000 | +6.6% | 817,398 | +0.7% | 0.15% | -1.3% |
| Q3 2013 | $53,327,000 | -44.1% | 811,798 | -41.0% | 0.15% | -48.0% |
| Q2 2013 | $95,343,000 | +83.4% | 1,376,398 | +92.3% | 0.29% | +70.9% |
| Q1 2013 | $51,994,000 | – | 715,773 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |